title: Memantine normalizes brain activity in the inferior frontal gyrus: a controlled pilot fMRI study.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Cerullo
authors.forename: Caleb M
authors.initials: CM
authors.lastname: Adler
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Strakowski
authors.forename: James C
authors.initials: JC
authors.lastname: Eliassen
authors.forename: Henry A
authors.initials: HA
authors.lastname: Nasrallah
authors.forename: Amelia T
authors.initials: AT
authors.lastname: Nasrallah
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D004292:Dominance, Cerebral / Q000502:physiology; D015259:Dopamine Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005260:Female; D005625:Frontal Lobe / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D008559:Memantine / Q000627:therapeutic use*; D011939:Mental Recall / Q000187:drug effects / Q000502:physiology; D010296:Parietal Lobe / Q000187:drug effects; D010865:Pilot Projects; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D015259:Dopamine Agents; D018691:Excitatory Amino Acid Antagonists; D008559:Memantine